Search Results

You are looking at 1 - 4 of 4 items for

  • Author: D J Scott x
  • Refine by access: All content x
Clear All Modify Search
J. E. Taylor
Search for other papers by J. E. Taylor in
Google Scholar
PubMed
Close
,
C. D. Scott
Search for other papers by C. D. Scott in
Google Scholar
PubMed
Close
, and
R. C. Baxter
Search for other papers by R. C. Baxter in
Google Scholar
PubMed
Close

ABSTRACT

Receptors for insulin-like growth factor II (IGF-II) have been compared in solubilized microsomal membranes from rat lung, brain, kidney, heart, epididymal and subcutaneous fat, ovary, testis and adrenals. Highest binding/μg protein was seen with testicular membranes. Receptors from all tissues showed high affinity for human IGF-II (mean association constant = 65 litres/nmol) and a high degree of specificity (mean IGF-I cross-reactivity 0·3%; no cross-reactivity with insulin). Affinity labelling followed by sodium dodecyl sulphate polyacrylamide gel electrophoresis showed binding was only to a type-II IGF receptor, with a major band seen at a molecular weight of about 230 000 in lung, brain, kidney and testis, and 240 000 in heart, fat and adrenal gland. All tissues showed broad or bimodal pH dependence of binding, with optima seen at about pH 6 and pH 9. Mild stimulation of IGF-II binding by low calcium concentrations (1–2 mmol/l) was seen in all tissues, although higher concentrations were inhibitory in the brain. It was concluded that IGF-II receptors from different rat tissues, when studied under uniform conditions, show similar binding affinities but differences in size and regulation which might be missed if receptors are examined in separate studies.

J. Endocr. (1987) 115, 35–41

Restricted access
Yongmei Wang Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Yongmei Wang in
Google Scholar
PubMed
Close
,
Takeshi Sakata Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Takeshi Sakata in
Google Scholar
PubMed
Close
,
Hashem Z Elalieh Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Hashem Z Elalieh in
Google Scholar
PubMed
Close
,
Scott J Munson Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Scott J Munson in
Google Scholar
PubMed
Close
,
Andrew Burghardt Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Andrew Burghardt in
Google Scholar
PubMed
Close
,
Sharmila Majumdar Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Sharmila Majumdar in
Google Scholar
PubMed
Close
,
Bernard P Halloran Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Bernard P Halloran in
Google Scholar
PubMed
Close
, and
Daniel D Bikle Department of Medicine, Endocrine Unit, Veterans Affairs Medical Center, University of California, San Francisco, California 94117-1080, USA
Department of Radiology, University of California, San Francisco, California 94117-1080, USA

Search for other papers by Daniel D Bikle in
Google Scholar
PubMed
Close

Parathyroid hormone (PTH) exerts both catabolic and anabolic actions on bone. Studies on the skeletal effects of PTH have seldom considered the effects of gender. Our study was designed to determine whether the response of mouse bone to PTH differed according to sex. As a first step, we analyzed gender differences with respect to bone mass and structural properties of 4 month old PTH treated (80 μg/kg per day for 2 weeks) male and female CD-1 mice. PTH significantly increased fat free weight/body weight, periosteal bone formation rate, mineral apposition rate, and endosteal single labeling surface, while significantly decreasing medullary area in male mice compared with vehicle treated controls, but induced no significant changes in female mice. We then analyzed the gender differences in bone marrow stromal cells (BMSC) isolated from 4 month old male and female CD-1 mice following treatment with PTH (80 μg/kg per day for 2 weeks). PTH significantly increased the osteogenic colony number and the alkaline phosphatase (ALP) activity (ALP/cell) by day 14 in cultures of BMSCs from male and female mice. PTH also increased the mRNA level of receptor activator of nuclear factor κB ligand in the bone tissue (marrow removed) of both females and males. However, PTH increased the mRNA levels of IGF-I and IGF-IR only in the bones of male mice. Our results indicate that on balance a 2-weeks course of PTH is anabolic on cortical bone in this mouse strain. These effects are more evident in the male mouse. These differences between male and female mice may reflect the greater response to PTH of IGF-I and IGF-IR gene expression in males enhancing the anabolic effect on cortical bone.

Free access
Laura M Clart Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Laura M Clart in
Google Scholar
PubMed
Close
,
Rebecca J Welly Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Rebecca J Welly in
Google Scholar
PubMed
Close
,
Eric D Queathem Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Eric D Queathem in
Google Scholar
PubMed
Close
,
R Scott Rector Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA
Internal Medicine-Division of Gastroenterology and Hepatology, University of Missouri System, Columbia, Missouri, USA
Research Service, Truman VA Memorial Hospital, Columbia, Missouri, USA

Search for other papers by R Scott Rector in
Google Scholar
PubMed
Close
,
Jaume Padilla Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA
Dalton Cardiovascular Research Center, University of Missouri System System, Columbia, Missouri, USA

Search for other papers by Jaume Padilla in
Google Scholar
PubMed
Close
,
Christopher P Baines Department of Biomedical Sciences, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Christopher P Baines in
Google Scholar
PubMed
Close
,
Jill A Kanaley Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Jill A Kanaley in
Google Scholar
PubMed
Close
,
Dennis B Lubahn Department of Biochemistry, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Dennis B Lubahn in
Google Scholar
PubMed
Close
, and
Victoria J Vieira-Potter Department of Nutrition and Exercise Physiology, University of Missouri System, Columbia, Missouri, USA

Search for other papers by Victoria J Vieira-Potter in
Google Scholar
PubMed
Close

Estrogen receptor β (ERb), one of the two major estrogen receptors, acts via genomic and non-genomic signaling pathways to affect many metabolic functions, including mitochondrial biogenesis and respiration. This study assessed the effect of ERb classical genomic activity on adipocyte-specific and -systemic metabolic responses to wheel running exercise in a rodent model of menopause. Female mice lacking the ERb DNA-binding domain (ERbDBDKO, n = 20) and WT (n = 21) littermate controls were fed a high-fat diet (HFD), ovariectomized (OVX), and randomized to control (no running wheel) and exercise (running wheel access) groups and were followed for 8 weeks. Wheel running did not confer protection against metabolic dysfunction associated with HFD+OVX in either ERbDBDKO or WT mice, despite increased energy expenditure. Unexpectedly, in the ERbDBDKO group, wheel running increased fasting insulin and surrogate measures of insulin resistance, and modestly increased adipose tissue inflammatory gene expression (P ≤ 0.05). These changes were not accompanied by significant changes in adipocyte mitochondrial respiration. It was demonstrated for the first time that female WT OVX mice do experience exercise-induced browning of white adipose tissue, indicated by a robust increase in uncoupling protein 1 (UCP1) (P ≤ 0.05). However, KO mice were completely resistant to this effect, indicating that full ERb genomic activity is required for exercise-induced browning. The inability to upregulate UCP1 with exercise following OVX may have resulted in the increased insulin resistance observed in KO mice, a hypothesis requiring further investigation.

Restricted access
P Fu Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by P Fu in
Google Scholar
PubMed
Close
,
P-J Shen Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by P-J Shen in
Google Scholar
PubMed
Close
,
C-X Zhao Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by C-X Zhao in
Google Scholar
PubMed
Close
,
D J Scott Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by D J Scott in
Google Scholar
PubMed
Close
,
C S Samuel Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by C S Samuel in
Google Scholar
PubMed
Close
,
J D Wade Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by J D Wade in
Google Scholar
PubMed
Close
,
G W Tregear Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by G W Tregear in
Google Scholar
PubMed
Close
,
R A D Bathgate Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by R A D Bathgate in
Google Scholar
PubMed
Close
, and
A L Gundlach Howard Florey Institute,
Department of Biochemistry and Molecular Biology,
Department of Anatomy and Cell Biology, The University of Melbourne, Victoria 3010, Australia

Search for other papers by A L Gundlach in
Google Scholar
PubMed
Close

Leucine-rich repeat-containing G-protein-coupled receptor 8 (LGR8, or RXFP2) is a member of the type C leucine-rich repeat-containing G protein-coupled receptor family, and its endogenous ligand is insulin-like peptide-3 (INSL3). Although LGR8 expression has been demonstrated in various human tissues, including testis, ovary, brain and kidney, the precise roles of this receptor in many of these tissues are unknown. In an effort to better understand INSL3–LGR8 systems in the rat, we cloned the full-length Lgr8 cDNA and investigated the presence and cellular localization of Lgr8 mRNA expression in adult and developing rat kidney. On the basis of these findings, we investigated the presence and distribution of renal 125I-labelled human INSL3-binding sites and the nature of INSL3–LGR8 signalling in cultured renal cells. Thus, using in situ hybridization histochemistry, cells expressing Lgr8 mRNA were observed in glomeruli of renal cortex from adult rats and were tentatively identified as mesangial cells. Quantitative, real-time PCR analysis of the developmental profile of Lgr8 mRNA expression in kidney revealed highest relative levels at late stage gestation (embryonic day 18), with a sharp decrease after birth and lowest levels in the adult. During development, silver grains associated with Lgr8 mRNA hybridization were observed overlying putative mesangial cells in mature glomeruli, with little or no signal associated with less-mature glomeruli. In adult and developing kidney, specific 125I-INSL3-binding sites were associated with glomeruli throughout the renal cortex. In primary cultures of glomerular cells, synthetic human INSL3 specifically and dose-dependently inhibited cell proliferation over a 48 h period, further suggesting the presence of functional LGR8 (receptors) on these cells (mesangial and others). These findings suggest INSL3–LGR8 signalling may be involved in the genesis and/or developmental maturation of renal glomeruli and possibly in regulating mesangial cell density in adult rat kidney.

Free access